AcquisitionsJul 16, 2026, 06:00 PM
IPG Photonics to Acquire Lumibird Medical for €300M
AI Summary
IPG Photonics Corporation announced a binding offer to acquire Lumibird Medical for €300 million in cash, with a potential earnout of up to €50 million. This acquisition is expected to accelerate IPG's strategic expansion in medical markets, particularly ophthalmology, complementing its existing strength in urology. The transaction is anticipated to be accretive to gross margin, EBITDA, and adjusted EPS, and will be funded with cash on hand. Lumibird Medical reported €112.2 million in revenue and €24.1 million in EBITDA for fiscal year 2025.
Key Highlights
- IPG Photonics to acquire Lumibird Medical for €300 million cash.
- Contingent earnout of up to €50 million based on 2026 and 2027 performance metrics.
- Acquisition expected to be accretive to gross margin, EBITDA, and adjusted EPS.
- Lumibird Medical reported €112.2 million revenue for fiscal year 2025.
- Lumibird Medical reported €24.1 million EBITDA for fiscal year 2025, with a 21.5% margin.
- Transaction expands IPG's addressable market for Advanced Solutions by approximately $1 billion.
- The acquisition is expected to close during the fourth quarter of 2026.
Price Impact
More from IPGP